SLC28A1
protein-codingsolute carrier family 28 member 1, the group of Solute carrier family 28
Gene summary
Enables azole transmembrane transporter activity; pyrimidine- and adenosine-specific:sodium symporter activity; and uridine transmembrane transporter activity. Involved in azole transmembrane transport and nucleoside transport. Located in apical plasma membrane. [provided by Alliance of Genome Resources, Jun 2026]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~61.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
Clinical Genomic Database (CGD)
Manifestation: Biochemical
Intervention: General
Rationale: The clinical relevance is unclear
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SLC28A1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004213.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 4 | 4 | 9 | ||
| missense | 87 | 5 | 3 | 95 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 2 | 2 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 0 | 91 | 9 | 7 | 107 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004204.3 | 17 | MANE Select | |
| Ensembl | ENSP00000378074.1 | 17 | MANE Select | |
| RefSeq | NP_001274690.1 | 14 | Standard | |
| RefSeq | NP_001274691.1 | 17 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Zidovudine Pathway, Pharmacokinetics/Pharmacodynamics
- Gemcitabine Pathway, Pharmacodynamics
- Capecitabine Action Pathway
- Capecitabine Metabolism Pathway
- Gemcitabine Action Pathway
Biological Process
- nucleobase-containing compound metabolic process
- pyrimidine nucleobase transport
- nucleoside transport
- pyrimidine-containing compound transmembrane transport
- nucleoside transmembrane transport
Molecular Function
- nucleoside transmembrane transporter activity
- nucleoside:sodium symporter activity
- pyrimidine- and adenine-specific:sodium symporter activity
Cellular Component
- plasma membrane
- integral component of plasma membrane
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000394573
- Coding exons
- 17
- Length
- 90992
- Individuals with no LoFs
- 125343
- Homozygous LoFs
- 2
- Heterozygous LoFs
- 403
- Defined
- 125748
- p
- 0.00161
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.742 | 393 | 354 | 1.11 | 0.0000224 | 4184 |
| Missense (PolyPhen) | 136 | 138.77 | 0.98004 | 1740 | ||
| Synonymous | -1.65 | 177 | 151 | 1.17 | 0.0000105 | 1331 |
| Loss of Function | 0.389 | 31 | 33.4 | 0.927 | 0.00000174 | 361 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.014 | 0.014 | notable |
| Latino/Admixed American | 0.0011 | 0.0011 | notable |
| Ashkenazi Jewish | 0.00099 | 0.00099 | rare |
| East Asian | 0.00022 | 0.00022 | rare |
| Finnish | 0.00010 | 0.000092 | rare |
| European (Non-Finnish) | 0.00041 | 0.00040 | rare |
| South Asian | 0.0024 | 0.0024 | notable |
| Other | 0.0013 | 0.0013 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Sodium-dependent and pyrimidine-selective. Exhibits the transport characteristics of the nucleoside transport system cit or N2 subtype (N2/cit) (selective for pyrimidine nucleosides and adenosine). It also transports the antiviral pyrimidine nucleoside analogs 3'-azido-3'-deoxythymidine (AZT) and 2',3'-dideoxycytidine (ddC). It may be involved in the intestinal absorption and renal handling of pyrimidine nucleoside analogs used to treat acquired immunodeficiency syndrome (AIDS). It has the following selective inhibition: adenosine, thymidine, cytidine, uridine >> guanosine, inosine.;
Recessive Scores
- pRec
- 0.171
Intolerance Scores
- LoFtool
- 0.876
- RVIS EVS
- 0.76
- RVIS percentile EVS
- 86.85
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.247
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |